Data-Driven Decision Making

After 15 years without new therapies, Tonix Pharma's TONMYA enters the fibromyalgia market with a unique sublingual drug and an ambitious commercial plan.

Concord Technologies' new platform merges fax and secure messaging, using AI to automate data flow, reduce burnout, and accelerate patient care.

The firm is integrating MSCI's advanced analytics platform, signaling a major shift towards hyper-personalized, data-driven advice for its clients.

A new study of 200,000+ AI citations reveals how AI search is upending traditional SEO, forcing wealth management firms to rethink their entire strategy.

A new AI-powered playbook from Aidentified aims to help financial advisors navigate the historic generational wealth transfer and modernize client prospecting.

A new AI-designed drug shows promise in selectively burning fat while preserving muscle, with a potential twice-yearly dosing schedule for obesity.

Major League Baseball's expanded partnership with Adobe ushers in a new era of AI-driven content, personalized engagement, and fan creativity.

IDEAYA Biosciences begins a key trial for its targeted therapy IDE892, aiming to conquer hard-to-treat tumors and pivoting to focus on its proprietary assets.

Praxis Solutions' new WealthHawk platform uses AI to find clients at key life events, aiming to end cold calling and solve the organic growth puzzle.

As cremation rates rise, Legacy Cremation Services unveils a major network expansion, promising to ease the burden on families with greater local access.

A new EU-backed initiative aims to win over UK and Swiss consumers by promoting the health benefits and authenticity of certified extra virgin olive oil.

The executive search giant's relocation from San Diego to Austin underscores the Texas capital's rise as a private equity and software powerhouse.

A massive wealth transfer is underway, and traditional financial advisors are losing their grip. Here's how specialized firms are winning this powerful new clientele.

MDClone launches ADAMS Copilot, a GenAI tool letting clinicians analyze data with simple questions, all while keeping sensitive information safe on-site.

A new report reveals a stark disconnect. While 41% of employers view AI as a team member, most employees are not convinced, creating a major workplace rift.

A new multi-year deal gives RNAi leader Alnylam access to Helix's vast genomic and clinical data, aiming to redefine the speed of drug discovery.

With data from 150M patients, SEQSTER's new platform promises to accelerate drug development, improve trial diversity, and make research-ready data a reality.

New research reveals a permanent shift in shopping, as AI tools and economic caution create a more deliberate, demanding, and less predictable consumer.

A new AI-powered platform claims it can solve higher education's financial woes by redesigning how universities operate. But can it deliver on its promise?

Education finance giant Sallie launches a new media network to monetize its student data, betting on a veteran team to capture the lucrative Gen Z market.